search icon
  • Print
  • ShareThis
  • Text Size

Antimicrobial Resistance

Antimicrobial resistance refers to microbes’ ability to change and become less susceptible to drugs. The development of antimicrobial drugs (antibacterials [antibiotics], antivirals, antifungals and antiparasitics) to treat otherwise life-threatening infections has been one of the most notable medical achievements in human history. The growing problem of resistance has undermined antimicrobials’ effectiveness resulting in the loss of countless lives and placing public health and national security at serious risk. IDSA is working on several policy fronts to counter these “bad bugs” and to save lives.

If you or a loved one have been devastated by an antibiotic resistant bacterial infection and you would like to share your story, please contact Jennifer Morales.

IDSA Initiatives to Address the Growing Antimicrobial Resistance Problem

Antibiotic Development: The 10x'20 Initiative

IDSA's regulatory and legislative effort to spur research and development of new antibiotics to treat serious and life-threatening bacterial infections.

Strengthening U.S. Efforts

IDSA supports legislative and administrative efforts to strengthen the U.S. response to antimicrobial resistance, such as enhanced coordination and leadership, surveillance, prevention and control, and research efforts.

Antimicrobial Stewardship

IDSA promotes the establishment of antimicrobial stewardship programs and integration of good stewardship practices in every health care facility across the United States.

In Agriculture

IDSA is working to eliminate inappropriate uses on antibiotics in food animals and other aspects of agriculture.

Average 3.5 out of 5

| HIVMA | Contact Us

© Copyright IDSA 2018 Infectious Diseases Society of America

Full Site Mobile Site